APA

Willemse P. H., Sleijfer D. T., Schraffordt Koops H., De Bruijn H. W., Oosterhuis J. W., Brouwers T. M., Ockhuizen T. & Marrink J. (19820120). The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis. : Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Chicago

Willemse P H, Sleijfer D T, Schraffordt Koops H, De Bruijn H W, Oosterhuis J W, Brouwers T M, Ockhuizen T and Marrink J. 19820120. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis. : Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Harvard

Willemse P. H., Sleijfer D. T., Schraffordt Koops H., De Bruijn H. W., Oosterhuis J. W., Brouwers T. M., Ockhuizen T. and Marrink J. (19820120). The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis. : Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

MLA

Willemse P H, Sleijfer D T, Schraffordt Koops H, De Bruijn H W, Oosterhuis J W, Brouwers T M, Ockhuizen T and Marrink J. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis. : Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine. 19820120.